dc.contributor.author | ZIRTILOGLU, A. | |
dc.contributor.author | Aydın, Eşref | |
dc.contributor.author | KARABULUT, S. | |
dc.contributor.author | CIL, I. | |
dc.contributor.author | Ekenel, MELTEM | |
dc.contributor.author | TURAL, Deniz | |
dc.date.accessioned | 2021-03-06T08:12:21Z | |
dc.date.available | 2021-03-06T08:12:21Z | |
dc.identifier.citation | Ekenel M., Aydın E., CIL I., ZIRTILOGLU A., TURAL D., KARABULUT S., "Sunitinib versus pazopanib for patients with metastatic renal cell carcinoma: Two Turkish hospital experience, a retrospective comparative case series study", 42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid, İspanya, 8 - 12 Eylül 2017, cilt.28 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_dfbbe989-847c-410e-9a3c-c0d36701e939 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/147401 | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Onkoloji | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Dahili Tıp Bilimleri | |
dc.title | Sunitinib versus pazopanib for patients with metastatic renal cell carcinoma: Two Turkish hospital experience, a retrospective comparative case series study | |
dc.type | Bildiri | |
dc.contributor.department | Bakirkoy Dr. Sadi Konuk Research & Training Hospital , , | |
dc.identifier.volume | 28 | |
dc.contributor.firstauthorID | 88838 | |